LifeSciences BC Brings Together Roster of Experts for Industry Roundtable – Angel Investments to Life Sciences Start-ups
January 28, 2009

In this tough economy, it's more important than ever to be on top of what you need to succeed, and LifeSciences BC was happy to bring our community another opportunity to improve their business development with a panel of speakers on Angel investments to life sciences start-up companies.

At the most recent LifeSciences BC Industry Roundtable, medical device, drug development and clean (bio) tech companies who are looking for investment opportunities had the chance to hear speakers from Natalus Life Science Capital (VCC) Ltd., Rocket Builders, and Ernst & Young.  Talks included "Everything you’ve always wanted to know about the Life Sciences Angel Network, "The secret to getting investment financing", "How SR&ED can help increase the investment value of your company", and "What is a VCC and why they matter to early stage companies."  Attendees also enjoyed the chance to network over breakfast. 

Look for more valuable development and networking opportunities coming soon - don't miss the next Industry Roundtable about EU Pharma Regulatory Updates on April 21, 2009.

 

Gordon Guild, President, Natalus Life Science Capital VCC Ltd. talks about the VCC role as attendees look on.